New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 1, 2014
14:08 EDTSLXPSalix price target raised to $121 from $115 at Cantor
Cantor Fitzgerald raised its price target for Salix Pharmaceuticals shares to $121 citing the positive top-line data for Xifaxan in IBS-D retreatment. The firm, however, thinks shares are fairly valued and reiterates a Hold rating on the stock.
News For SLXP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for SLXP

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use